BET inhibitor I-BET726 effect on MYCN-amplified neuroblastoma cell line CHP-212: dose response - - GEO DataSets - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

Full record GDS5364

BET inhibitor I-BET726 effect on MYCN-amplified neuroblastoma cell line CHP-212: dose response

Analysis of CHP-212 neuroblastoma (NB) cells treated with 0.1 or 1 uM I-BET726, a BET inhibitor. MYCN is amplified in CHP-212. BET inhibitors display anti-proliferative activity in MYC driven hematologic cancer models. Results provide insight into the anti-proliferative activity of I-BET726 in NB.

Organism:: Homo sapiens

Type:: Expression profiling by array, transformed count, 2 agent, 3 dose sets

Platform:: GPL10558
Series:: GSE47386
9 Samples

DataSet

Accession:: GDS5364

ID:: 5364

PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet

Supplemental Content

Related information

PubMed
Related PubMed entries
Full text in PMC
PMC links
Similar studies
Similar studies
GEO Profiles
Related GEO
BioProject
BioProject links
GEO DataSets
Related GEO DataSets
Taxonomy
Taxonomy

Important Links

Recent activity

Clear Turn Off Turn On

BET inhibitor I-BET726 effect on MYCN-amplified neuroblastoma cell line CHP-212:...
BET inhibitor I-BET726 effect on MYCN-amplified neuroblastoma cell line CHP-212: dose response
Accession: GDS5364

GEO DataSets
Related DataSets for GEO Profiles (Select 123507848) (1)
GEO DataSets

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Genes & Expression > Gene Expression Omnibus (GEO) Datasets